| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 114.44M | — |
| Operating expense | — | — |
| Net income | -17.74M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, WGS returned -32.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -33.1% |
| 1 year | -32.3% |
| 5 years | -72.2% |
| All-time high | $660.33 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in WGS would be worth today ›No. GeneDx Holdings Corp. has not paid a dividend in the past 12 months.
GeneDx Holdings Corp. stock trades on NASDAQ under the ticker symbol WGS.
GeneDx Holdings Corp. is part of the Healthcare sector.
GeneDx Holdings Corp. has a market cap of 2.60B USD, based on the latest quote.
GeneDx Holdings Corp. is expected to report earnings around Oct 27, 2026. That date is an estimate and has not been confirmed by the company.
